No difference in disease onset was observed, thus confirming that depletion of PRDM15 in the lymphoma cells, rather than in the tumor microenvironment, is crucial for attenuation of lymphomagenesis (Fig. 3h). This evidence concerns the gene PRDM15 and lymphoma.